This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
3 Oil ETFs to Ride the Crude Rally
by Neena Mishra
We highlight 3 popular ETFs that track oil prices using futures
5 Leveraged Energy ETFs to Play Geopolitical Tensions in Gulf
by Sanghamitra Saha
Leveraged energy ETFs are likely to be intriguing plays currently as United Arab Emirates has vowed to retaliate against Houthi militants for the attack that set off explosions in fuel trucks, causing a fire near the airport in Abu Dhabi.
Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit
by Sanghamitra Saha
Pfizer is likely to launch Omicron vaccine in March while Moderna is working on a booster that targets the omicron variant of Covid-19.
Grab These ETFs to Ride the Latest Rally in Oil Prices
by Sweta Jaiswal, FRM
Take a look at some ETFs that can benefit from the latest rally in oil prices due to a variety of factors including easing Omicron variant concerns.
Top ETF Stories of Fourth-Quarter 2021
by Sanghamitra Saha
The year 2021 as a whole could easily be attributed to the reopening trades after an edgy 2020 thanks to the outbreak of COVID-19 and the resultant lockdown.
Energy Emerges Best Sector of the Week: 5 ETFs That Topped
by Sanghamitra Saha
Oil price surged last week on rally in reopening trades. Bets that the new COVID-19 variant Omicron may cause milder illness than previously feared, fears over further lockdowns have been eased and the economic-reopening-friendly investments jumped along with the broader market.
7 Best Leveraged ETFs of Last Week
by Sanghamitra Saha
Overall, last week was upbeat for Wall Street with the S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 gaining about decently. The rally was spurred by bets that the new COVID-19 variant Omicron may cause milder illness than previously feared.
Why Reopening-Friendly ETFs Can be Bought on the Dip?
by Sanghamitra Saha
Omicron is believed to be less severe than Delta by some experts while President Biden is not planning to impose lockdown now. With economies and citizens having learnt to deal with COVID variants in the past two years, fresh global shutdown is less likely.
Top ETF Stories of November
by Sanghamitra Saha
The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
by Sanghamitra Saha
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.